Erik Petersen
Psychiatry · Huntington Beach, CANPI 1922210251
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,767, more than ten times the $130 reported in 2019.
Across 107 payments — averaging $27.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$498
- AbbVie$393
- Alkermes, Inc.$295
- Otsuka America Pharmaceutical, Inc.$273
- E.r. Squibb & Sons, L.L.C.$254
- Neurocrine Biosciences, Inc.$232
- plus $967 from 12 others
What the payments were for
- Food & beverage$2,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $498 |
| AbbVie | 17 | $393 |
| Alkermes, Inc. | 7 | $295 |
| Otsuka America Pharmaceutical, Inc. | 10 | $273 |
| E.r. Squibb & Sons, L.L.C. | 10 | $254 |
| Neurocrine Biosciences, Inc. | 8 | $232 |
| Teva Pharmaceuticals USA, Inc. | 11 | $201 |
| Biogen | 6 | $135 |
| Axsome Therapeutics, Inc. | 5 | $123 |
| Avanir Pharmaceuticals, Inc. | 1 | $110 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| Indivior Inc. | 2 | $65 |
| Lundbeck LLC | 3 | $61 |
| Corium, LLC | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 2 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,912 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 33 | $88,462 |
| Invega SustennaPaliperidone Palmitate | 28 | $77,626 |
| VraylarCariprazine Hcl | 38 | $56,003 |
| RexultiBrexpiprazole | 27 | $39,278 |
| Lurasidone Hcl | 53 | $26,249 |
| Aripiprazole | 136 | $16,995 |
| Clozapine | 34 | $2,845 |
| Quetiapine Fumarate | 131 | $2,637 |
| Olanzapine | 148 | $2,450 |
| Paliperidone ErPaliperidone | 28 | $2,139 |
| Oxcarbazepine | 53 | $1,462 |
| Ziprasidone Hcl | 23 | $1,206 |
| Trazodone Hcl | 178 | $1,056 |
| Bupropion XlBupropion Hcl | 32 | $1,005 |
| Gabapentin | 65 | $866 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $273 | $127,74060 claims |
| Johnson & JohnsonInvega Sustenna | $498 | $77,62628 claims |
| AbbVieVraylar | $393 | $56,00338 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Huntington Beach
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.